Tivicay® (dolutegravir) 50-mg tablets for HIV-1
FDA has approved Viiv Healthcare’s integrase inhibitor Tivicay® (dolutegravir) 50-mg tablets, for use with other antiretroviral agents in treating HIV-1 infection. ViiV Healthcare is an HIV therapeutics company established in 2009 by GlaxoSmithKline and Pfizer. Tivicay is indicated for...Tags: HIV-1, HIV, Drug, Computational Chemistry
3906 days ago
SCFBio have developed Sanjeevini
SCFBio have developed a new android based application for drug design called Sanjeevini (https://play.google.com/store/apps/details?id=com.sanjeevini&hl=en). It is available free of charge. You can download it using Google play store. Just search for "Sanjeevini-SCFBIO-CADD" in...Tags: SCFBio, Delhi, IITD, android, application, drug, design, Sanjeevini
2352 days ago